Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan
· Delayed Price · Currency is TWD 12.90
+0.10 (0.78%)
May 14, 2025, 10:59 AM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 5.44 billion as of May 13, 2025. Its market cap has decreased by -21.43% in one year.
Market Cap
5.44B
Enterprise Value
5.26B
Revenue
4.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.90
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has increased from 5.10B to 5.44B, an increase of 6.62%. That is a compound annual growth rate of 2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 5.44B | -1.02% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 171.52B |
| Caliway Biopharmaceuticals | 110.55B |
| Bora Pharmaceuticals Co., LTD. | 74.21B |
| Lotus Pharmaceutical | 60.03B |
| Polaris Group | 33.16B |
| Oneness Biotech | 28.27B |
| Pegavision | 26.95B |
| Lumosa Therapeutics | 26.52B |